Squires David A
International Program in Health Policy and Innovation, Commonwealth Fund, USA.
Issue Brief (Commonw Fund). 2011 Jul;16:1-14.
The Organization for Economic Cooperation and Development (OECD) tracks and reports on more than 1,200 health system measures across 34 industrialized countries. This analysis concentrated on 2010 OECD health data for Australia, Canada, Denmark, France, Germany, Netherlands, New Zealand, Norway, Sweden, Switzerland, the United Kingdom, and the United States. Health care spending in the U.S. towers over the other countries. The U.S. has fewer hospital beds and physicians, and sees fewer hospital and physician visits, than in most other countries. Prescription drug utilization, prices, and spending all appear to be highest in the U.S., as does the supply, utilization, and price of diagnostic imaging. U.S. performance on a limited set of quality measures is variable, ranking highly on five-year cancer survival, middling on in-hospital case-specific mortality, and poorly on hospital admissions for chronic conditions and amputations due to diabetes. Findings suggest opportunities for cross-national learning to improve health system performance.
经济合作与发展组织（OECD）对34个工业化国家的1200多项卫生系统指标进行跟踪和报告。本分析集中于OECD 2010年澳大利亚、加拿大、丹麦、法国、德国、荷兰、新西兰、挪威、瑞典、瑞士、英国和美国的卫生数据。美国的医疗保健支出远高于其他国家。与大多数其他国家相比，美国的医院床位和医生数量较少，住院和看医生的次数也较少。美国的处方药使用量、价格和支出似乎都是最高的，诊断成像的供应、使用和价格也是如此。美国在一套有限的质量指标上的表现参差不齐，在五年癌症生存率方面排名很高，在医院特定病例死亡率方面排名中等，在慢性病住院率和糖尿病截肢方面表现不佳。研究结果表明存在跨国学习以改善卫生系统绩效的机会。
